In April 2025, the UK Medicines and Healthcare products Regulatory Agency (MHRA) implemented a revised clinical trials framework following its public consultation on regulatory reform. Sponsors are now expected to submit through the Combined Review, a coordinated ethics and regulatory process with a target timeline of 150 days. It changes what gets submitted, when, and […]
